A significant role of transcription factors E2F in inflammation and tumorigenesis of nasopharyngeal carcinoma
Authors:
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 524 (4) , 816-824
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81672889, 81874170)
- 111 Project (111-2-12)
- Hunan province science and technology project (2016JC2035)
This publication has 28 references indexed in Scilit:
- Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancerGenome Research, 2013
- Emerging roles of E2Fs in cancer: an exit from cell cycle controlNature Reviews Cancer, 2009
- The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinomaThe Journal of Pathology, 2008
- Genome-Wide Expression Profiling Reveals EBV-Associated Inhibition of MHC Class I Expression in Nasopharyngeal CarcinomaCancer Research, 2006
- Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progressionJournal of Cellular Biochemistry, 2006
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- A Susceptibility Locus at Chromosome 3p21 Linked to Familial Nasopharyngeal CarcinomaCancer Research, 2004
- BRD7, a novel bromodomain gene, inhibits G1–S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathwaysJournal of Cellular Physiology, 2004
- RB Associates with an E2F-like, Sequence-specific DNA-binding ProteinCold Spring Harbor Symposia on Quantitative Biology, 1991
- E2F Transcription Factor Is a Target for the RB Protein and the Cyclin A ProteinCold Spring Harbor Symposia on Quantitative Biology, 1991